Industry reports
Editor highlights

Prescription Drug Industry in South Korea: Market Research Reports, Statistics and Analysis

» View Public Reports

10 reports

Company Report: Prescription Drug in Japan, South Korea and The United States for Year 2012

  • Company report
  • November 2012
  • 22 pages

... Y-y -3.7 13.5 1.2 -17.3 -10.8 -11.6 -7.1 -9.5 -10.0 -1.0 Source: ubist, woori i&s research center daewoong: monthly top-10 outpatient prescription drugs (unit: wbn ...

Company Report: Prescription Drug in South Korea for Year 2012

  • Company report
  • October 2012
  • 6 pages

... Is similar to last year, but op grew 3%yoy to krw29.1Bn, which beats market expectations (krw20.9Bn) by a large margin. Even with weak prescription drug earnings following drug price cuts in apr, profitability ...

Company Report: Prescription Drug in South Korea for Year 2012

  • Company report
  • March 2012
  • 4 pages
  • by Corporation

... drugs and apis, and increasing equity method income from yuhan kimberly and yuhan chemical ind. 2013 Adjusted eps to jump 27%yoy thanks to flagship business growth and increase in equity method gains 2 ...

Company Report: Prescription Drug in South Korea for Year 2012

  • Company report
  • January 2012
  • 16 pages
  • by Corporation

... On domestic prescription drug sales and major players Earnings for some time. We advise investors to pay attention selectively to stocks that are less sensitive to domestic demand and poised to see tangible ...

Company Report: Prescription Drug in South Korea and The United States for Year 2011

  • Company report
  • March 2011
  • 6 pages

... Than-expected earnings thanks to strong drink product and outpatient prescription drug sales. The processed food unit saw solid sales volume growth for pre-cooked rice, trional sauces, and processed meat products ...

Company Report: Prescription Drug in China and South Korea for Year 2011

  • Company report
  • March 2011
  • 6 pages
  • by Corporation

... On k-gaap stand-alone; k-ifrs parent basis from 2011 source: company data, hyundai securities fig 2: op to rebound in 2h12 amid full-scale growth of new products, such as prescription drugs and apis ...

Company Report: Prescription Drug in South Korea for Year 2011

  • Company report
  • March 2011
  • 6 pages

... Is similar to last year, but op grew 3%yoy to krw29.1Bn, which beats market expectations (krw20.9Bn) by a large margin. Even with weak prescription drug earnings following drug price cuts in apr, profitability ...

Company Report: Prescription Drug in South Korea for Year 2011

  • Company report
  • March 2011
  • 4 pages
  • by Corporation

... In prescription drug sales amid a worsening operating environment; 2) a deteriorated product mix stemming from an increase in licensed-in items; and 3) declines in other operating income, such as r&d support ...

Company Report: Prescription Drug in South Korea and The United States for Year 2011

  • Company report
  • March 2011
  • 6 pages

... Daewoo securities research figure 1. Growth rate of outpatient prescription drug sales (yoy) figure 2. Sk chemicals p/e band source: kdb daewoo securities research source: kdb daewoo securities ...

Company Report: Prescription Drug in South Korea for Year 2008

  • Company report
  • November 2008
  • 6 pages

... Outlook: pharmaceuticals (neutral) prescription drug demand to fall in 2009; market releases of generic drugs ...

Search in Prescription Drug Industry

» Purchase Premium Reports (From $ 99 - $ 99)

1 report
Daewoong Pharmaceutical Co., Ltd.: Company Profile and SWOT Analysis

Daewoong Pharmaceutical Co., Ltd.: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • December 2011
  • by ICD Research

Synopsis ICD Research's "Daewoong Pharmaceutical Co., Ltd.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.